Springbok legend Tendai 'Beast' Mtawarira believes South Africans have reached a crossroads in the conversation surrounding the Black Lives Matter (BLM) movement.Inspired by national captain Siya Kolisi's powerful stance on the matter last weekend, Mtawarira took to Instagram to add his voice.Born in Zimbabwe and having had his Springbok status temporarily threatened by the South…
Tendai 'Beast' Mtawarira starts his role as CEO of a new company, Umlindi Security. SA's third-most capped Springbok has been a brand ambassador for Fidelity for nearly nine years.Mtawarira is also a shareholder in the company.Springbok legend Tendai 'Beast' Mtawarira has taken the step into the corporate world, officially starting in his role as chief executive…
Springbok Sevens legend Cecil Afrika's national contract will run its course at the end of July.He played 12 seasons on the World Rugby Sevens Series circuit.The 32-year-old, however, has not given up hope of playing in the next Olympics.Springbok Sevens legend Cecil Afrika has stepped down from international sevens duty.Afrika, 32, on Monday ended his…
Springboks 2020-06-04 15:51 Bryan Habana hopes Pieter-Steph du Toit will be able to maximise on his commercial opportunities.Du Toit has opted to stay at the Stormers despite having received lucrative offers abroad.Habana expects 'goalposts to shift' after next year's British & Irish Lions tour.Springbok legend Bryan Habana has sympathised with Pieter-Steph du Toit and Malcolm…
Paul OâConnell (Getty Images) Former captain Paul O'Connell says it will be vital for the British & Irish Lions to pick a leader capable of beating the Springboks at their own game next year.Register your interest for the British & Irish Lions tickets in South Africa 2021The former Ireland lock, who captained the Lions when…
The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment
Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase — from $34 a month to $51 — by switching to lower-cost plans during the program’s open enrollment period, which runs through Dec.
You don't have permission to access "http://www.medpagetoday.com/washington-watch/washington-watch/123652" on this server. Reference #18.d494d817.1793332899.22e6a54f https://errors.edgesuite.net/18.d494d817.1793332899.22e6a54f